Genomic Health Delivers First Quarterly Profit; Lowers Guidance | GenomeWeb

By a GenomeWeb staff reporter

This article has been updated from a previous version to include comments from company officials.

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Wednesday that its second-quarter revenues increased 19 percent year over year, and the firm posted its first-ever quarterly profit.

However, citing "market and economic conditions," the firm lowered its revenue and earnings guidance for the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.